Laurence Harewood

Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, Patrick Bowden, Anthony J Costello, Laurence Harewood, Niall M Corcoran, Phil Dundee, Justin S Peters, Nathan Lawrentschuk, Andrew Troy, David Webb, Yee Chan, Andrew See, Shankar Siva, Declan Murphy, Michael S Hofman, Ben Tran

Journal article  |  2020  |  BJU International

Prostate-specific membrane antigen (PSMA) PET/CT imaging is increasingly being utilised in clinical practice, demonstrating greate..

Use of PSMA PET/CT to Assess Treatment Response Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer (MPC)

Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, Patrick Bowden, Tony Costello, Laurence Harewood, Niall Corcoran, Phil Dundee, Justin Peters, Nathan Lawrentschuk, Andrew Troy, David Webb, Yee Chan, Andrew See, Shankar Siva, Declan Murphy, Michael S Hofman, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy

A Anton, Z Ballok, P Bowden, T Costello, L Harewood, N Corcoran, P Dundee, J Peters, N Lawrentschuk, A Troy, D Webb, Y Chan, A See, S Siva, D Murphy, MS Hofman, B Tran

Conference Proceedings  |  2018  |  Annals of Oncology

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A Selth, Stephen Q Wong, Laura H Porter, Natalie Lister, David Pook, Carmel J Pezaro, David L Goode, Richard J Rebello, Ashlee K Clark, Melissa Papargiris, Jenna Van Gramberg, Adrienne R Hanson, Patricia Banks, Hong Wang, Birunthi Niranjan, Shivakumar Keerthikumar, Shelley Hedwards, et al.

Journal article  |  2018  |  European Urology

Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens

Liam Toner, Nathan Papa, Marlon Perera, Nikolas Katelaris, Mahesha Weerakoon, Kwang Chin, Laurence Harewood, Damien M Bolton, Nathan Lawrentschuk

Journal article  |  2017  |  World Journal of Urology

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

Ryan Stuchbery, Geoff Macintyre, Marek Cmero, Laurence M Harewood, Justin S Peters, Anthony J Costello, Christopher M Hovens, Niall M Corcoran

Journal article  |  2016  |  ONCOTARGET

Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?

Fairleigh Reeves, Christopher M Hovens, Laurence Harewood, Shane Battye, Justin S Peters, Anthony J Costello, Niall M Corcoran

Journal article  |  2015  |  Canadian Urological Association Journal

Assessing expression of MUC1 and ZAG protein biomarkers in prostate biopsies improves prediction of adverse pathology following radical prostatectomy

N Durrani, M Waldron, C Cherry, L Harewood, M Frydenberg, J Pedersen, J Mills

Journal article  |  2015  |  The Open Prostate Cancer Journal

Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer

James G Huang, John Pedersen, Matthew KH Hong, Laurence M Harewood, Justin Peters, Anthony J Costello, Chris M Hovens, Niall M Corcoran

Journal article  |  2013  |  BJU International

Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer

Nikhil Sapre, John Pedersen, Matthew K Hong, Laurence Harewood, Justin Peters, Anthony J Costello, Chris M Hovens, Niall M Corcoran

Journal article  |  2012  |  BJU International